Breaking News Instant updates and real-time market news.

WMK

Weis Markets

$56.19 /

-0.37 (-0.65%)

16:34
11/01/21
11/01
16:34
11/01/21
16:34

Weis Markets reports Q3 EPS $1.06 vs. $1.16 last year

Reports Q3 revenue $1.06B vs. $1.02B last year. "We continued to generate strong results in the third quarter," said Weis Markets CEO Jonathan Weis. "Our hardworking and dedicated associates are the key to our success. They continue to help us meet the challenges of a pandemic-impacted marketplace, including a tight labor market, supply chain disruptions impacting product availability, and product cost inflation resulting in some consumer resistance and a changing sales mix. Their success is our success."

OTHER BREAKING NEWS FROM THE FLY

Conference/Events
Alnylam to host conference call » 19:25
09/30/22
09/30
19:25
09/30/22
19:25
ALNY

Alnylam

$200.28 /

-9.16 (-4.37%)

Management will discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALNY Alnylam
$200.28 /

-9.16 (-4.37%)

ALNY Alnylam
$200.28 /

-9.16 (-4.37%)

09/20/22 RBC Capital
Alnylam price target raised to $250 from $225 at RBC Capital
09/20/22 Citi
Citi opens 'upside catalyst watch' on Alnylam Pharmaceuticals
09/16/22 Canaccord
Regeneron price target raised to $750 from $700 at Canaccord
09/09/22 Oppenheimer
Alnylam price target raised to $256 from $170 at Oppenheimer
ALNY Alnylam
$200.28 /

-9.16 (-4.37%)

ALNY Alnylam
$200.28 /

-9.16 (-4.37%)

Periodicals
Intel's Mobileye Global files for IPO, Bloomberg reports » 18:27
09/30/22
09/30
18:27
09/30/22
18:27
INTC

Intel

$25.78 /

-0.605 (-2.29%)

Intel has filed for an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

09/23/22 Morgan Stanley
AMD price target lowered to $95 from $102 at Morgan Stanley
09/08/22 Deutsche Bank
Intel price target lowered to $35 from $38 at Deutsche Bank
09/07/22 Stifel
Stifel starts Intel at Hold with turnaround in 'early innings'
09/07/22 Stifel
Stifel starts AMD at Buy with $122 price target
INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

Hot Stocks
Boeing awarded $188.03M Air Force contract modification » 17:45
09/30/22
09/30
17:45
09/30/22
17:45
BA

Boeing

$121.17 /

-4.18 (-3.33%)

Boeing has been awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$121.17 /

-4.18 (-3.33%)

BA Boeing
$121.17 /

-4.18 (-3.33%)

09/27/22 Morgan Stanley
Boeing's China and MAX 10 risks overdone at current levels, says Morgan Stanley
09/23/22 BofA
Losing Xiamen to Airbus another setback for Boeing, says BofA
09/14/22 Jefferies
Woodward downgraded to Hold from Buy at Jefferies
09/08/22 Morgan Stanley
Boeing price target raised to $233 from $215 at Morgan Stanley
BA Boeing
$121.17 /

-4.18 (-3.33%)

BA Boeing
$121.17 /

-4.18 (-3.33%)

BA Boeing
$121.17 /

-4.18 (-3.33%)

BA Boeing
$121.17 /

-4.18 (-3.33%)

Hot Stocks
Raytheon Technologies awarded $225.64M Navy contract » 17:38
09/30/22
09/30
17:38
09/30/22
17:38
RTX

Raytheon Technologies

$81.86 /

-0.48 (-0.58%)

Raytheon was awarded a…

Raytheon was awarded a $225.64M cost-plus-fixed-fee contract for AIM-9X Block II and Block II+ System Improvement Program Increment IV to include hardware and software development to the AIM-9X system as well as test and integration of developed hardware and capabilities. More specifically the hardware development will include updates to the AIM-9X sensor, electronics unit, and guidance unit and the software efforts include the development of the operational flight software versions 10.5 and 11.5 and integrated flight software. Additionally, this contract provides program protection, cyber security, information assurance and training for the AIM-9X system. Work is expected to be completed in September 2027. This contract was not competitively procured pursuant to Defense Federal Acquisition Regulation 6.302-1. The Naval Air Systems Command is the contracting activity.

ShowHide Related Items >><<
RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

07/27/22 Wells Fargo
Raytheon Technologies price target lowered to $98 from $106 at Wells Fargo
07/27/22 RBC Capital
Raytheon Technologies price target lowered to $115 from $125 at RBC Capital
04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

Hot Stocks
Lockheed Martin awarded $228.68M Navy contract modification » 17:34
09/30/22
09/30
17:34
09/30/22
17:34
LMT

Lockheed Martin

$386.99 /

-2.72 (-0.70%)

Lockheed Martin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

09/28/22 Wells Fargo
Wells Fargo downgrades Lockheed to sell, says will 'under-grow' peers
09/28/22 Wells Fargo
Lockheed Martin downgraded to Underweight from Equal Weight at Wells Fargo
08/29/22 RBC Capital
Lockheed Martin initiated with a Sector Perform at RBC Capital
07/20/22 Wells Fargo
Lockheed Martin price target lowered to $406 from $496 at Wells Fargo
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

Hot Stocks
Flexible Solutions announces termination of merger pact with Lygos » 17:31
09/30/22
09/30
17:31
09/30/22
17:31
FSI

Flexible Solutions

$1.65 /

-0.05 (-2.94%)

Flexible Solutions and…

Flexible Solutions and Lygos have agreed to terminate the Merger Agreement between the parties. FSI and Lygos remain committed to finding routes to sustainable aspartic acid and the myriad sustainable and biodegradable products that can be made from aspartic acid. Neither FSI nor Lygos will let the termination of the merger agreement prevent them from working together in other ways to achieve the goal of sustainable aspartic acid.

ShowHide Related Items >><<
FSI Flexible Solutions
$1.65 /

-0.05 (-2.94%)

FSI Flexible Solutions
$1.65 /

-0.05 (-2.94%)

11/16/21 Greenridge
Flexible Solutions upgraded to Buy from Hold at Greenridge
FSI Flexible Solutions
$1.65 /

-0.05 (-2.94%)

FSI Flexible Solutions
$1.65 /

-0.05 (-2.94%)

Hot Stocks
Raytheon Technologies awarded $232.78M Navy contract » 17:31
09/30/22
09/30
17:31
09/30/22
17:31
RTX

Raytheon Technologies

$81.86 /

-0.48 (-0.58%)

Raytheon Technologies was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

07/27/22 Wells Fargo
Raytheon Technologies price target lowered to $98 from $106 at Wells Fargo
07/27/22 RBC Capital
Raytheon Technologies price target lowered to $115 from $125 at RBC Capital
04/27/22 Argus
Raytheon Technologies price target raised to $112 from $100 at Argus
04/27/22 Cowen
Raytheon Technologies price target raised to $120 from $115 at Cowen
RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

RTX Raytheon Technologies
$81.86 /

-0.48 (-0.58%)

Syndicate
Worksport files $30M mixed securities shelf  17:24
09/30/22
09/30
17:24
09/30/22
17:24
WKSP

Worksport

$1.75 /

+0.06 (+3.55%)

 
ShowHide Related Items >><<
WKSP Worksport
$1.75 /

+0.06 (+3.55%)

WKSP Worksport
$1.75 /

+0.06 (+3.55%)

11/29/21 Maxim
Worksport initiated with a Buy at Maxim
11/29/21 Maxim
Worksport initiated with a Buy at Maxim
Hot Stocks
Lockheed Martin awarded $265.59M Navy contract modification » 17:23
09/30/22
09/30
17:23
09/30/22
17:23
LMT

Lockheed Martin

$386.99 /

-2.72 (-0.70%)

Lockheed Martin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

09/28/22 Wells Fargo
Wells Fargo downgrades Lockheed to sell, says will 'under-grow' peers
09/28/22 Wells Fargo
Lockheed Martin downgraded to Underweight from Equal Weight at Wells Fargo
08/29/22 RBC Capital
Lockheed Martin initiated with a Sector Perform at RBC Capital
07/20/22 Wells Fargo
Lockheed Martin price target lowered to $406 from $496 at Wells Fargo
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

Hot Stocks
Lockheed Martin awarded $350.4M Navy contract modification » 17:19
09/30/22
09/30
17:19
09/30/22
17:19
LMT

Lockheed Martin

$386.99 /

-2.72 (-0.70%)

Lockheed Martin was…

Lockheed Martin was awarded a $350.4M cost-plus-incentive-fee and cost-plus-fixed-fee un-priced letter contract modification to a previously awarded and announced unpriced letter contract for program management, engineering development, systems integration, long lead material procurement, and special tooling and equipment procurement in support of missile production. This contract award contains option line items. Work is expected to be completed on November 9, 2026 once the contract is definitized. FY21 research, development, test, and evaluation funds in the amount of $2.85M will be obligated on this award and will expire at the end of the current fiscal year. FY22 research, development, test, and evaluation funds in the amount of $24.28M will be obligated on this award and will not expire at the end of the current fiscal year. This contract is being awarded to the contractor on a sole source basis under 10 U.S.C. 2304(c)(1) and was previously synopsized on the System for Award Management online portal. Strategic Systems Programs is the contracting activity.

ShowHide Related Items >><<
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

09/28/22 Wells Fargo
Wells Fargo downgrades Lockheed to sell, says will 'under-grow' peers
09/28/22 Wells Fargo
Lockheed Martin downgraded to Underweight from Equal Weight at Wells Fargo
08/29/22 RBC Capital
Lockheed Martin initiated with a Sector Perform at RBC Capital
07/20/22 Wells Fargo
Lockheed Martin price target lowered to $406 from $496 at Wells Fargo
LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

LMT Lockheed Martin
$386.99 /

-2.72 (-0.70%)

Hot Stocks
Fluor awarded $1.33B Navy contract modification » 17:15
09/30/22
09/30
17:15
09/30/22
17:15
FLR

Fluor

$24.89 /

+0.45 (+1.84%)

Fluor was awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLR Fluor
$24.89 /

+0.45 (+1.84%)

FLR Fluor
$24.89 /

+0.45 (+1.84%)

08/08/22 Citi
Fluor price target lowered to $26 from $27 at Citi
07/22/22 Citi
Fluor price target lowered to $27 from $31 at Citi
05/09/22 Citi
Fluor price target raised to $31 from $29 at Citi
02/23/22 Baird
Baird upgrades 'inexpensive' Fluor to Outperform
FLR Fluor
$24.89 /

+0.45 (+1.84%)

Syndicate
Amprius Technologies files to sell 16.83M shares of common stock for holders  17:11
09/30/22
09/30
17:11
09/30/22
17:11
AMPX

Ampex Corp

$9.26 /

-0.24 (-2.53%)

 
ShowHide Related Items >><<
AMPX Ampex Corp
$9.26 /

-0.24 (-2.53%)

AMPX Ampex Corp
$9.26 /

-0.24 (-2.53%)

Hot Stocks
Lytus Technologies receives noncompliance notice from Nasdaq » 17:09
09/30/22
09/30
17:09
09/30/22
17:09
LYT

Lytus Technologies

$1.60 /

+0.08 (+5.26%)

Lytus Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LYT Lytus Technologies
$1.60 /

+0.08 (+5.26%)

  • 14
    Apr
Periodicals
Bundesliga reopens investment talks with KKR, Blackstone, others, FT says » 17:08
09/30/22
09/30
17:08
09/30/22
17:08
KKR

KKR

$43.01 /

-0.28 (-0.65%)

, BX

Blackstone

$83.72 /

-0.77 (-0.91%)

Germany's Bundesliga…

Germany's Bundesliga football league has reopened discussions with buyout groups over a multibillion-euro investment, the Financial Times' Josh Noble and Kaye Wiggins reports. In recent weeks, executives from Deutsche Fussball Liga, which runs the Bundesliga, have held early discussions with private equity firms, including Advent, Blackstone (BX), Bridgepoint, CVC, and KKR (KKR), the authors say, citing two people familiar with the matter. One option discussed would be to establish an entity that would control Bundesliga's media and commercial rights, valuing them at as much as EUR18B, and then raise up to EUR4.5B by selling a 25% interest to external investors, the authors note. Reference Link

ShowHide Related Items >><<
KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

KKR KKR
$43.01 /

-0.28 (-0.65%)

08/12/22 Deutsche Bank
KKR price target raised to $68 from $65 at Deutsche Bank
07/13/22 Deutsche Bank
KKR price target lowered to $66 from $79 at Deutsche Bank
07/12/22 JMP Securities
KKR price target lowered to $80 from $85 at JMP Securities
07/11/22 Piper Sandler
KKR price target lowered to $80 from $86 at Piper Sandler
BX Blackstone
$83.72 /

-0.77 (-0.91%)

08/31/22 Barclays
Blackstone initiated with an Overweight at Barclays
08/12/22 Deutsche Bank
Blackstone price target raised to $153 from $147 at Deutsche Bank
07/25/22 Piper Sandler
Blackstone price target lowered to $120 from $154 at Piper Sandler
07/24/22 Keefe Bruyette
Blackstone downgraded to Market Perform from Outperform at Keefe Bruyette
KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

  • 08
    Dec
KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

KKR KKR
$43.01 /

-0.28 (-0.65%)

BX Blackstone
$83.72 /

-0.77 (-0.91%)

Syndicate
Xos files to sel 11.57M shares of common stock for holders  17:08
09/30/22
09/30
17:08
09/30/22
17:08
XOS

Xos

$1.23 /

-0.04 (-3.15%)

 
ShowHide Related Items >><<
XOS Xos
$1.23 /

-0.04 (-3.15%)

XOS Xos
$1.23 /

-0.04 (-3.15%)

08/12/22 DA Davidson
Xos price target lowered to $5 from $11 at DA Davidson
07/15/22 Northland
Sunworks and Sunnova could trade down on Manchin news, says Northland
06/03/22 Northland
Xos initiated with an Outperform at Northland
12/08/21 BofA
Xos initiated with an Underperform at BofA
XOS Xos
$1.23 /

-0.04 (-3.15%)

XOS Xos
$1.23 /

-0.04 (-3.15%)

Syndicate
Predictive Oncology files to sell 4.74M shares of common stock for holders  17:08
09/30/22
09/30
17:08
09/30/22
17:08
POAI

Predictive Oncology

/

+

 
ShowHide Related Items >><<
POAI Predictive Oncology
/

+

Syndicate
Warrior Met Coal files automatic mixed securities shelf  17:07
09/30/22
09/30
17:07
09/30/22
17:07
HCC

Warrior Met Coal

$28.44 /

-0.59 (-2.03%)

 
ShowHide Related Items >><<
HCC Warrior Met Coal
$28.44 /

-0.59 (-2.03%)

HCC Warrior Met Coal
$28.44 /

-0.59 (-2.03%)

09/23/22 B. Riley
Warrior Met Coal upgraded to Buy from Neutral at B. Riley
08/03/22 BMO Capital
Warrior Met Coal downgraded to Market Perform from Outperform at BMO Capital
07/07/22 B. Riley
Warrior Met Coal price target raised to $48 from $45 at B. Riley
06/07/22 Jefferies
Warrior Met Coal upgraded to Buy from Hold at Jefferies
HCC Warrior Met Coal
$28.44 /

-0.59 (-2.03%)

Hot Stocks
Regeneron reports 'positive' results from trials of novel aflibercept 8mg » 17:06
09/30/22
09/30
17:06
09/30/22
17:06
REGN

Regeneron

$689.40 /

-2.865 (-0.41%)

Regeneron announced the…

Regeneron announced the first presentations of positive detailed results from two pivotal trials investigating novel aflibercept 8 mg with 12- and 16-week dosing regimens, compared to EYLEA Injection, in patients with diabetic macular edema and wet age-related macular degeneration. The data were presented in a late-breaking session at the American Academy of Ophthalmology annual meeting in Chicago and will support the submission of a new Biologics License Application to the U.S. FDA by early 2023. "Our presentations at AAO demonstrate that aflibercept 8 mg 12- and 16-week dosing regimens have achieved a high bar, sustaining improvements in visual acuity and anatomic measures of retinal fluid across 48 weeks in patients with diabetic macular edema and wet age-related macular degeneration," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer at Regeneron, and a principal inventor of aflibercept. "These results were all achieved in patients who were rapidly initiated on extended dosing intervals with the vast majority not requiring regimen modification. Altogether, the pivotal data support aflibercept 8 mg as providing a longer duration of action while maintaining a safety profile similar to EYLEA." As presented at AAO, the PHOTON trial in DME and the PULSAR trial in wAMD both met the same primary endpoint. Aflibercept 8 mg demonstrated non-inferiority in vision gains in both the 12- and 16-week dosing regimens after initial monthly doses at 48 weeks compared to an EYLEA 8-week dosing regimen. Furthermore, 91% and 89% of DME patients and 79% and 77% of wAMD patients respectively randomized to 12- and 16-week dosing maintained those intervals through 48 weeks. The safety of aflibercept 8 mg was similar to EYLEA in both trials, and consistent with the known safety profile of EYLEA from previous clinical trials. Comparing aflibercept 8 mg to EYLEA, ocular adverse events occurred in 31% versus 28% in PHOTON and 38% versus 39% in PULSAR, and there were no cases of retinal vasculitis, occlusive retinitis or endophthalmitis in either trial.

ShowHide Related Items >><<
REGN Regeneron
$689.40 /

-2.865 (-0.41%)

REGN Regeneron
$689.40 /

-2.865 (-0.41%)

09/16/22 Canaccord
Regeneron price target raised to $750 from $700 at Canaccord
09/13/22 Piper Sandler
Regeneron price target raised to $775 from $692 at Piper Sandler
09/12/22 Piper Sandler
Regeneron data at ESMO showcases 'power' of oncology pipeline, says Piper
09/12/22 Guggenheim
Regeneron price target raised to $925 from $740 at Guggenheim
REGN Regeneron
$689.40 /

-2.865 (-0.41%)

REGN Regeneron
$689.40 /

-2.865 (-0.41%)

REGN Regeneron
$689.40 /

-2.865 (-0.41%)

REGN Regeneron
$689.40 /

-2.865 (-0.41%)

Hot Stocks
Stealth Biotherapeutics announces resignation of CFO Robert Weiskopf » 17:01
09/30/22
09/30
17:01
09/30/22
17:01
MITO

Stealth Biotherapeutics

/

+

Stealth BioTherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MITO Stealth Biotherapeutics
/

+

MITO Stealth Biotherapeutics
/

+

05/23/22 H.C. Wainwright
Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright
MITO Stealth Biotherapeutics
/

+

Periodicals
Intel's Mobileye Global files for IPO, Bloomberg reports » 16:59
09/30/22
09/30
16:59
09/30/22
16:59
INTC

Intel

$25.78 /

-0.605 (-2.29%)

Mobileye Global will seek…

Mobileye Global will seek listing on Nasdaq under ticker symbol "MBLY."

ShowHide Related Items >><<
INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

09/23/22 Morgan Stanley
AMD price target lowered to $95 from $102 at Morgan Stanley
09/08/22 Deutsche Bank
Intel price target lowered to $35 from $38 at Deutsche Bank
09/07/22 Stifel
Stifel starts Intel at Hold with turnaround in 'early innings'
09/07/22 Stifel
Stifel starts AMD at Buy with $122 price target
INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

INTC Intel
$25.78 /

-0.605 (-2.29%)

Syndicate
Nutex Health files to sell 196.32M shares of common stock for holders  16:59
09/30/22
09/30
16:59
09/30/22
16:59
NUTX

Nutex Health

$1.50 /

-0.12 (-7.41%)

 
ShowHide Related Items >><<
NUTX Nutex Health
$1.50 /

-0.12 (-7.41%)

NUTX Nutex Health
$1.50 /

-0.12 (-7.41%)

NUTX Nutex Health
$1.50 /

-0.12 (-7.41%)

Hot Stocks
Robinhood raises restructuring charge estimate to $90M-$105M from $45M-$60M » 16:57
09/30/22
09/30
16:57
09/30/22
16:57
HOOD

Robinhood

$10.09 /

+0.32 (+3.28%)

In a regulatory filing,…

In a regulatory filing, the company said, "As we continue to execute the August 2022 Restructuring, our lower headcount has led us to evaluate our real estate portfolio. On September 30, 2022, we decided to partially or completely close five additional offices as part of the August 2022 Restructuring, four of which are recent leases that have not been occupied. No employees are being terminated as a result of these actions. We expect these additional office closures will result in incremental restructuring-related charges of approximately $45 million (substantially all of which will be incurred in the third quarter of 2022), and we expect this decision will generate additional run-rate savings of approximately $4 million per quarter, starting in the fourth quarter of 2022 and running through the first quarter of 2024, and savings of lesser amounts thereafter. As a result of these actions, we are revising our originally estimated restructuring charge range of $45 million to $60 million; our new estimate is that we will incur total restructuring-related charges of approximately $90 million to $105 million (excluding the impact of share-based compensation) in connection with the August 2022 Restructuring, substantially all of which we expect to incur in the third quarter of 2022. This updated range consists of approximately $30 million to $40 million of cash restructuring and related charges (as originally estimated) primarily related to employee severance and benefits costs (excluding the impact of share-based compensation) and approximately $60 million to $65 million of charges related to office closures and contract termination fees (including impairments of approximately $50 million). We continue to expect a net reversal of share-based compensation of $40 million to $50 million in the third quarter of 2022 as a result of the August 2022 Restructuring, as described in the Original 8-K. If we subsequently determine that we will incur additional material restructuring costs or charges or there are material differences from the ranges provided above, we will file another amendment to the Original 8-K to disclose any such material costs, charges, or differences."

ShowHide Related Items >><<
HOOD Robinhood
$10.09 /

+0.32 (+3.28%)

HOOD Robinhood
$10.09 /

+0.32 (+3.28%)

09/13/22 JPMorgan
Robinhood August monthly metrics 'uninspiring,' says JPMorgan
08/31/22 Atlantic Equities
Robinhood price target raised to $7 from $5 at Atlantic Equities
08/31/22 Barclays
Robinhood downgraded to Underweight from Equal Weight at Barclays
08/19/22 JPMorgan
Robinhood net sales 'slowed meaningfully' in July, says JPMorgan
HOOD Robinhood
$10.09 /

+0.32 (+3.28%)

HOOD Robinhood
$10.09 /

+0.32 (+3.28%)

HOOD Robinhood
$10.09 /

+0.32 (+3.28%)

HOOD Robinhood
$10.09 /

+0.32 (+3.28%)

Conference/Events
Curaleaf to participate in a conference call with Cantor Fitzgerald » 16:54
09/30/22
09/30
16:54
09/30/22
16:54
CURLF

Curaleaf

$4.94 /

-0.02 (-0.40%)

Analyst Cannabis holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CURLF Curaleaf
$4.94 /

-0.02 (-0.40%)

CURLF Curaleaf
$4.94 /

-0.02 (-0.40%)

08/09/22 Canaccord
Curaleaf price target lowered to C$13.50 from C$14.50 at Canaccord
08/09/22 Alliance Global Partners
Curaleaf price target lowered to C$12 from C$15 at Alliance Global Partners
08/09/22 Cowen
Curaleaf price target lowered to $10 from $25 at Cowen
07/22/22 Seaport Global
Curaleaf initiated with a Buy at Seaport Global
CURLF Curaleaf
$4.94 /

-0.02 (-0.40%)

CURLF Curaleaf
$4.94 /

-0.02 (-0.40%)

CURLF Curaleaf
$4.94 /

-0.02 (-0.40%)

Hot Stocks
Scorpio Tankers purchases 224,000 of its common shares in the open market » 16:44
09/30/22
09/30
16:44
09/30/22
16:44
STNG

Scorpio Tankers

$42.06 /

+0.23 (+0.55%)

On September 30, the…

On September 30, the company purchased 224,000 of its common shares in the open market at an average price of $42.24 per share as part of the company's securities repurchase program.

ShowHide Related Items >><<
STNG Scorpio Tankers
$42.06 /

+0.23 (+0.55%)

STNG Scorpio Tankers
$42.06 /

+0.23 (+0.55%)

09/06/22 Deutsche Bank
Scorpio Tankers price target raised to $34 from $10.50 at Deutsche Bank
07/29/22 B. Riley
Scorpio Tankers price target raised to $50 from $45 at B. Riley
07/28/22 BTIG
Scorpio Tankers price target raised to $50 from $42 at BTIG
07/20/22 Jefferies
Scorpio Tankers initiated with a Buy at Jefferies
STNG Scorpio Tankers
$42.06 /

+0.23 (+0.55%)

STNG Scorpio Tankers
$42.06 /

+0.23 (+0.55%)

Hot Stocks
NaaS Technology Inc. CFO Lei Zhao resigns, Alex Wu named interim CFO » 16:43
09/30/22
09/30
16:43
09/30/22
16:43
NAAS

NaaS Technology Inc.

$4.28 /

-0.15 (-3.39%)

NaaS Technology Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAAS NaaS Technology Inc.
$4.28 /

-0.15 (-3.39%)

NAAS NaaS Technology Inc.
$4.28 /

-0.15 (-3.39%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.